| Primary |
| Rheumatoid Arthritis |
22.2% |
| Abdominal Pain Upper |
7.4% |
| Antibiotic Prophylaxis |
7.4% |
| Pain |
7.4% |
| Anal Spasm |
3.7% |
| Antifungal Prophylaxis |
3.7% |
| Antiviral Prophylaxis |
3.7% |
| Constipation |
3.7% |
| Convulsion |
3.7% |
| Drug Toxicity Prophylaxis |
3.7% |
| Gastritis Erosive |
3.7% |
| Gastrointestinal Inflammation |
3.7% |
| Gastrooesophageal Reflux Disease |
3.7% |
| Hypertension |
3.7% |
| Insomnia |
3.7% |
| Nausea |
3.7% |
| Ovarian Neoplasm |
3.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.7% |
| Vomiting |
3.7% |
|
| Abscess |
11.8% |
| Haematochezia |
11.8% |
| Anaphylactic Shock |
5.9% |
| Cardiovascular Disorder |
5.9% |
| Cough |
5.9% |
| Drug Exposure During Pregnancy |
5.9% |
| Eczema |
5.9% |
| Headache |
5.9% |
| Hepatitis C |
5.9% |
| Hypoparathyroidism Secondary |
5.9% |
| Melaena |
5.9% |
| Rash Morbilliform |
5.9% |
| Respiratory Depression |
5.9% |
| Swollen Tongue |
5.9% |
| Tachycardia |
5.9% |
|
| Secondary |
| Sepsis |
14.0% |
| Cholangitis |
8.0% |
| Drug Use For Unknown Indication |
8.0% |
| Product Used For Unknown Indication |
7.3% |
| Hypertension |
5.3% |
| Peptic Ulcer |
5.3% |
| Pruritus |
5.3% |
| Vomiting |
5.3% |
| Cardiac Failure |
4.7% |
| Thrombosis Prophylaxis |
4.7% |
| Barrett's Oesophagus |
4.0% |
| Rheumatoid Arthritis |
4.0% |
| Tremor |
4.0% |
| Pain |
3.3% |
| Prophylaxis |
3.3% |
| Cholelithiasis |
2.7% |
| Gastroenteritis |
2.7% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Helicobacter Infection |
2.7% |
| Hypotension |
2.7% |
|
| Toxic Epidermal Necrolysis |
22.6% |
| Fractured Sacrum |
9.7% |
| Urticaria |
9.7% |
| Erythema |
6.5% |
| Laparotomy |
6.5% |
| Pruritus |
6.5% |
| Rash Maculo-papular |
6.5% |
| Abdominal Abscess |
3.2% |
| Agranulocytosis |
3.2% |
| Cholestatic Liver Injury |
3.2% |
| Intentional Drug Misuse |
3.2% |
| Myalgia |
3.2% |
| Pulmonary Embolism |
3.2% |
| Rash |
3.2% |
| Self Injurious Behaviour |
3.2% |
| Sopor |
3.2% |
| Stevens-johnson Syndrome |
3.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
14.9% |
| Product Used For Unknown Indication |
11.7% |
| Ascites |
10.1% |
| Prophylaxis |
9.4% |
| Hypertension |
9.2% |
| Multiple Myeloma |
4.9% |
| Sepsis |
4.7% |
| Atrial Fibrillation |
4.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.5% |
| Premedication |
2.9% |
| Rheumatoid Arthritis |
2.9% |
| Non-small Cell Lung Cancer |
2.8% |
| Myocardial Ischaemia |
2.6% |
| Diabetes Mellitus |
2.5% |
| Glycogen Storage Disease Type Ii |
2.5% |
| Prophylaxis Of Nausea And Vomiting |
2.5% |
| Stomatitis |
2.4% |
| Gastric Disorder |
2.1% |
| Infection Prophylaxis |
2.1% |
| Hepatic Neoplasm Malignant |
2.0% |
|
| Vomiting |
10.3% |
| Sepsis |
8.6% |
| Weight Decreased |
8.6% |
| Megacolon |
6.9% |
| Shock |
6.0% |
| Thrombocytopenia |
6.0% |
| Chronic Myelomonocytic Leukaemia |
5.2% |
| Hyperthermia |
5.2% |
| Melaena |
5.2% |
| Anaemia |
4.3% |
| Osteonecrosis |
4.3% |
| Gastrointestinal Perforation |
3.4% |
| Meningitis Pneumococcal |
3.4% |
| Purpura |
3.4% |
| Rash |
3.4% |
| Renal Failure Chronic |
3.4% |
| Rhabdomyolysis |
3.4% |
| Stevens-johnson Syndrome |
3.4% |
| Acute Coronary Syndrome |
2.6% |
| Hypotension |
2.6% |
|
